Latest News
- Fla. Docs Can Soon Deny Patient Care Over Personal Beliefs
- New Guidance on Neurological Complications of Long-COVID
- Alert FDA Approves Upadacitinib (Rinvoq) for Crohn's Disease
- 'Robust Evidence' That Exercise Cuts Parkinson Risk in Women
- Former Immunomedics CFO Pleads Guilty to Insider Trading
- Tagrisso, Chemo Combo Shows Promise in Lung Cancer Trial
- EU, United States Launch Joint Health Task Force
- Amgen's Antitrust Woes Spur Wider Pharmaceutical Deal Fears
- Age-Specific Cut-Offs Needed for Cardiac Troponin Tests?
- Overdose Deaths Mark Another Record Year, but Experts Hopeful
- EuroPCR 2023 Evidence of TAVR Benefit Extends to Cardiogenic Shock
- Patritumab Deruxtecan Shows Promise for Breast Cancer
- ECO 2023 Half of Teens Drop Below Obesity Cutoff With Semaglutide
- Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
- 7 Things to Know About Bats and Pandemic Risk
- DeSantis Signs Ban on Transgender Treatment for Minors
- The Antimicrobial Peptide That Even Pharma Can Love
- FDA Staff Flag 'Serious' Safety Risks for NASH Treatment
- DLBCL: Major New Treatment Breakthroughs
- Teach Basic Lifesaving Skills Starting Age 4, AHA Advises